Full Press Release Details
INDIANAPOLIS , May 23, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will host a webcast on Tuesday, June 7, 2022 to discuss the company's diabetes and obesity portfolio and its presentations at the American Diabetes Association's 82nd Scientific Sessions. The webcast will begin at 11:30 a.m. Eastern time and remarks will focus on results from the tirzepatide SURMOUNT-1 clinical trial, as well as Lilly's once-weekly basal insulin and early-phase incretins.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
| Refer to: | Jordan Bishop; [email protected] ; 317-473-5712 (Media) |
| Kevin Hern; [email protected] ; 317-277-1838 (Investors) |
SOURCE Eli Lilly and Company